Literature DB >> 12621630

Reliability of reported age at onset for Parkinson's disease.

Carson R Reider1, Cheryl A Halter, Peter F Castelluccio, David Oakes, William C Nichols, Tatiana Foroud.   

Abstract

An individual's age at onset of Parkinson disease (PD) can be collected through a variety of sources, including medical records, family report, and clinical observation. The most common source of PD age at onset information in the research setting is family-report, which is then typically used to classify a subject as juvenile, young, or late age at onset. The reliability of the family-reported age at onset of PD has not been rigorously examined. The present study used data from individuals diagnosed with PD to evaluate the reliability of age at onset information by comparing data obtained from three sources: 1) the subject's medical records, 2) a Family History Questionnaire, and 3) a Subject History Questionnaire. Among the 149 subjects with data for all three age at onset sources, the estimated reliability was R = 0.94. Similar reliability was observed when the sample was stratified based on gender, age at examination, disease duration, first symptom of PD, and years of education. The three measures of age at onset of PD show excellent agreement, strengthening confidence in the reliability of the reported age of clinical onset for PD. Copyright 2002 Movement Disorder Society

Entities:  

Mesh:

Year:  2003        PMID: 12621630     DOI: 10.1002/mds.10391

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  12 in total

1.  Clinical heterogeneity in newly diagnosed Parkinson's disease.

Authors:  Bart Post; Johannes D Speelman; Rob J de Haan
Journal:  J Neurol       Date:  2008-03-17       Impact factor: 4.849

2.  Connecting Gaucher and Parkinson Disease: Considerations for Clinical and Research Genetic Counseling Settings.

Authors:  Lola Cook; Jeanine Schulze
Journal:  J Genet Couns       Date:  2017-06-30       Impact factor: 2.537

3.  Changes in age at diagnosis of type 2 diabetes mellitus in the United States, 1988 to 2000.

Authors:  Richelle J Koopman; Arch G Mainous; Vanessa A Diaz; Mark E Geesey
Journal:  Ann Fam Med       Date:  2005 Jan-Feb       Impact factor: 5.166

4.  Age of onset: can we rely on essential tremor patients to report this? Data from a prospective, longitudinal study.

Authors:  Elan D Louis
Journal:  Neuroepidemiology       Date:  2012-10-24       Impact factor: 3.282

5.  Nitric oxide synthase genes and their interactions with environmental factors in Parkinson's disease.

Authors:  Dana B Hancock; Eden R Martin; Jeffery M Vance; William K Scott
Journal:  Neurogenetics       Date:  2008-07-29       Impact factor: 2.660

6.  Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder.

Authors:  R B Postuma; J F Gagnon; M Vendette; M L Fantini; J Massicotte-Marquez; J Montplaisir
Journal:  Neurology       Date:  2008-12-24       Impact factor: 9.910

7.  No evidence for DNM3 as genetic modifier of age at onset in idiopathic Parkinson's disease.

Authors:  Victoria Berge-Seidl; Lasse Pihlstrøm; Zbigniew K Wszolek; Owen A Ross; Mathias Toft
Journal:  Neurobiol Aging       Date:  2018-09-22       Impact factor: 4.673

8.  The effect of age of onset of PD on risk of dementia.

Authors:  D Aarsland; J T Kvaløy; K Andersen; J P Larsen; M X Tang; A Lolk; P Kragh-Sørensen; K Marder
Journal:  J Neurol       Date:  2007-02-14       Impact factor: 4.849

9.  Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach.

Authors:  S J G Lewis; T Foltynie; A D Blackwell; T W Robbins; A M Owen; R A Barker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-03       Impact factor: 10.154

10.  Genomewide association study for onset age in Parkinson disease.

Authors:  Jeanne C Latourelle; Nathan Pankratz; Alexandra Dumitriu; Jemma B Wilk; Stefano Goldwurm; Gianni Pezzoli; Claudio B Mariani; Anita L DeStefano; Cheryl Halter; James F Gusella; William C Nichols; Richard H Myers; Tatiana Foroud
Journal:  BMC Med Genet       Date:  2009-09-22       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.